<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0026">
 <label>26</label>
 <element-citation publication-type="journal" id="sbref0022">
  <person-group person-group-type="author">
   <name>
    <surname>Ahmed</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Merrill</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Alsawah</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Bockenstedt</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Campagnaro</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Devata</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial</article-title>
  <source>Lancet Haematol</source>
  <volume>6</volume>
  <year>2019</year>
  <fpage>e630</fpage>
  <lpage>e637</lpage>
  <pub-id pub-id-type="pmid">31537486</pub-id>
 </element-citation>
</ref>
